MJN228

CAS: 459168-97-9

Ref. 3D-JTA16897

Produktinformation

• Name: MJN228
• Marke: Biosynth
• Beschreibung: MJN228 is an experimental drug that binds to a specific site on the protein. It is being developed as a potential treatment for obesity, diabetes, and other metabolic diseases. MJN228 has been shown to bind to lipids, which are fatty molecules that are important in metabolism. Binding of MJN228 to these lipids may alter the way they interact with proteins.

Chemische Eigenschaften

• Molekulargewicht: 364.4 g/mol
• Formel: C₂₀H₂₀N₄O₃
• Reinheit: Min. 95%